发明名称 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
摘要 Compounds of formula I, wherein the substituents are as defined in the specification, are useful for inhibiting sodium and calcium channels, and for treating acute, chronic, neuropathic, or inflammatory pain, arthritis, migraine, cluster headaches, trigeminal neuralgia, herpetic neuralgia, general neuralgias, epilepsy or epileptic conditions, neurodegenerative disorders, psychiatric disorders, anxiety, depression, myotonia, arrhythmia, movement disorders, neuroendocrine disorders, ataxia, multiple sclerosis, irritable bowel syndrome, incontinence, visceral pain, osteoarthritis pain, postherpetic neuralgia, diabetic neuropathy, radicular pain, sciatica, back pain, head or neck pain, severe or intractable pain, nociceptive pain, breakthrough pain, postsurgical pain, and cancer pain. Novel compounds of formula I-A are also disclosed.
申请公布号 NZ545710(A) 申请公布日期 2010.02.26
申请号 NZ20040545710 申请日期 2004.08.09
申请人 VERTEX PHARMACEUTICALS INCORPORATED 发明人 GONZALES, JESUS E;TERMIN, ANDREAS P;MARTINBOROUGH, ESTHER;ZIMMERMAN, NICOLE
分类号 C07D285/12;A61K31/513;A61K31/517;A61K31/522;A61K31/5377;A61K31/5415;C07C311/44;C07C311/46;C07C311/51;C07D209/80;C07D209/92;C07D213/76;C07D231/38;C07D231/42;C07D237/20;C07D237/22;C07D239/42;C07D239/46;C07D239/52;C07D239/54;C07D239/545;C07D239/69;C07D241/22;C07D261/16;C07D263/50;C07D277/52;C07D277/82;C07D285/125;C07D285/135;C07D295/26;C07D401/12;C07D403/12;C07D405/12;C07D405/14;C07D407/12;C07D409/12;C07D413/12;C07D417/12;C07D417/14;C07D513/04 主分类号 C07D285/12
代理机构 代理人
主权项
地址